Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aura Biosciences Inc.

    NASDAQ: AURA · Real-Time Price · USD
    6.41
    -0.26 (-3.90%)
    At close: Jun 13, 2025, 3:59 PM
    6.74
    5.15%
    After-hours: Jun 13, 2025, 04:20 PM EDT

    Aura Biosciences Statistics

    Share Statistics

    Aura Biosciences has 62M shares outstanding. The number of shares has increased by 1.38% in one year.

    Shares Outstanding

    n/a
    		 62M

    Shares Change (YoY)

    n/a
    		 1.38%

    Shares Change (QoQ)

    n/a
    		 0.55%

    Owned by Institutions (%)

    n/a
    		 79.43%

    Shares Floating

    n/a
    		 46.58M

    Failed to Deliver (FTD) Shares

    n/a
    		 677

    FTD / Avg. Volume

    n/a
    		 0.23%

    Short Selling Information

    The latest short interest is 2.64M, so 4.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.64M

    Short % of Shares Out

    n/a
    		 4.26%

    Short % of Float

    n/a
    		 4.85%

    Short Ratio (days to cover)

    n/a
    		 10.66

    Valuation Ratios

    The PE ratio is -4.7 and the forward PE ratio is -3.46. Aura Biosciences's PEG ratio is 0.5.

    PE Ratio

    n/a
    		 -4.7

    Forward PE

    n/a
    		 -3.46

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.6

    PB Ratio

    n/a
    		 2.69

    P/FCF Ratio

    n/a
    		 -5.03

    PEG Ratio

    n/a
    		 0.5
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aura Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.12.

    Current Ratio

    n/a
    		 10.77

    Quick Ratio

    n/a
    		 10.77

    Debt / Equity

    n/a
    		 0.12

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 -0.23

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-819,990.57

    Employee Count

    n/a
    		 106

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 112K

    Effective Tax Rate

    n/a
    		 -0.13%

    Stock Price Statistics

    The stock price has increased by -12.55% in the last 52 weeks. The beta is 0.42, so Aura Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.42

    52-Week Price Change

    n/a
    		 -12.55%

    50-Day Moving Average

    n/a
    		 5.76

    200-Day Moving Average

    n/a
    		 7.83

    Relative Strength Index (RSI)

    n/a
    		 54.7

    Average Volume (20 Days)

    n/a
    		 297,939

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -96.12M

    Net Income

    n/a
    		 -86.92M

    EBITDA

    n/a
    		 -85.58M

    EBIT

    n/a
    		 -86.81M

    Earnings Per Share (EPS)

    n/a
    		 -1.75
    Full Income Statement

    Balance Sheet

    The company has 31.69M in cash and 18.77M in debt, giving a net cash position of 12.92M.

    Cash & Cash Equivalents

    n/a
    		 31.69M

    Total Debt

    n/a
    		 18.77M

    Net Cash

    n/a
    		 12.92M

    Retained Earnings

    n/a
    		 -374.23M

    Total Assets

    n/a
    		 155.4M

    Working Capital

    n/a
    		 122.35M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -79.81M and capital expenditures -1.25M, giving a free cash flow of -81.06M.

    Operating Cash Flow

    n/a
    		 -79.81M

    Capital Expenditures

    n/a
    		 -1.25M

    Free Cash Flow

    n/a
    		 -81.06M

    FCF Per Share

    n/a
    		 -1.63
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AURA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AURA is $22, which is 243.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 243.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.89

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist